Studies on lung cancer cells have shown that MAPK1 phosphorylation inhibits FASN expression [15], while MAPK1 activation enhances the expression of fatty acid metabolism genes such as CPT1a in diabetic cardiomyopathy [36]. This evidence concerns the gene CPT1A and lung carcinoma.